SCHEMBL2964070

SCHEMBL2964070

[CH]C(C)S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL82656 0.72
SCHEMBL5250 0.72
SCHEMBL330158 0.72
SCHEMBL2755195 0.67
SCHEMBL2956483 0.67
SCHEMBL4732383 0.67
SCHEMBL8031293 0.67
SCHEMBL1525899 0.67
Potassium SCHEMBL1581738 0.67 ALDH1A1 (0.33)
SCHEMBL7659527 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9737638-B2 Polyester amide copolymers having free carboxylic acid pendant groups ABBOTT CARDIOVASCULAR SYSTEMS, INC. (US) 2017-08-22 US disclosed
US-20140147687-A1 BIOLOGICALLY ABSORBABLE COATING FOR IMPLANTABLE DEVICES BASED ON COPOLYMERS HAVING ESTER BONDS AND METHODS OF FABRICATING THE SAME ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) 2014-05-29 US disclosed
US-20140147686-A1 BIOLOGICALLY ABSORBABLE COATING FOR IMPLANTABLE DEVICES BASED ON COPOLYMERS HAVING ESTER BONDS AND METHODS OF FABRICATING THE SAME ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) 2014-05-29 US disclosed
US-7771739-B2 Implantable medical devices comprising semi-crystalline poly(ester-amide) ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) 2010-08-10 US disclosed
US-20080314289-A1 Polyester amide copolymers having free carboxylic acid pendant groups ABBOTT CARDIOVASCULAR SYSTEMS, INC. 2008-12-25 US disclosed
WO-2008157254-A2 POLYESTER AMIDE COPOLYMERS HAVING FREE CARBOXYLIC ACID PENDANT GROUPS ABBOTT CARDIOVASCULAR SYSTEMS, INC. (US) 2008-12-24 WO disclosed
US-20080014238-A1 biodegradable stents; atherosclerosis, thrombosis, restenosis, hemorrhage, vascular dissection or perforation, vascular aneurysm, vulnerable plaque, chronic total occlusion, claudication, type-II diabetes, anastomotic proliferation for vein and artificial grafts, bile duct obstruction, ureter obstruction ABBOTT CARDIOVASCULAR SYSTEMS INC. 2008-01-17 US disclosed
EP-1789105-A2 BIOABSORBABLE POLY(ESTER AMIDE) COATINGS FOR IMPLANTABLE DEVICES ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) 2007-05-30 EP disclosed
WO-2005089824-A2 BIOABSORBABLE POLY (ESTER AMIDE) COATINGS FOR IMPLANTABLE DEVICES ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) 2005-09-29 WO disclosed
US-20050208091-A1 Biologically absorbable coatings for implantable devices based on copolymers having ester bonds and methods for fabricating the same ADVANCED CARDIOVASCULAR SYSTEMS, INC. 2005-09-22 US disclosed